Inter Pharma Public Company Limited
Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probio… Read more
Inter Pharma Public Company Limited (IP) - Total Liabilities
Latest total liabilities as of September 2025: ฿936.19 Million THB
Based on the latest financial reports, Inter Pharma Public Company Limited (IP) has total liabilities worth ฿936.19 Million THB as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Inter Pharma Public Company Limited - Total Liabilities Trend (2016–2024)
This chart illustrates how Inter Pharma Public Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Inter Pharma Public Company Limited Competitors by Total Liabilities
The table below lists competitors of Inter Pharma Public Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Heran Co Ltd
TW:5283
|
Taiwan | NT$3.23 Billion |
|
PT Wintermar Offshore Marine Tbk
F:W6O
|
Germany | €49.91 Million |
|
Bcl Industries Limited
NSE:BCLIND
|
India | ₹7.94 Billion |
|
Agile Content SA
MC:AGIL
|
Spain | €76.44 Million |
|
Astec LifeSciences Limited
NSE:ASTEC
|
India | ₹4.69 Billion |
|
Osmanli Menkul Degerler AS
IS:OSMEN
|
Turkey | TL1.87 Billion |
|
BLS E-Services Limited
NSE:BLSE
|
India | ₹1.71 Billion |
|
Woongjin Thinkbig Co Ltd
KO:095720
|
Korea | ₩478.64 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Inter Pharma Public Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inter Pharma Public Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inter Pharma Public Company Limited (2016–2024)
The table below shows the annual total liabilities of Inter Pharma Public Company Limited from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ฿866.40 Million | +3.80% |
| 2023-12-31 | ฿834.65 Million | -12.35% |
| 2022-12-31 | ฿952.25 Million | +75.19% |
| 2021-12-31 | ฿543.54 Million | +107.25% |
| 2020-12-31 | ฿262.27 Million | +336.13% |
| 2019-12-31 | ฿60.13 Million | -29.39% |
| 2018-12-31 | ฿85.16 Million | +229.05% |
| 2017-12-31 | ฿25.88 Million | -39.68% |
| 2016-12-31 | ฿42.90 Million | -- |